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Abstract
Background: Chronic cough is a common problem, frequently caused or exacerbated by acid
reflux. Diagnosis of acid reflux cough is haphazard currently, often relying on long therapeutic trials
of expensive medications. We tested the hypothesis that the most relevant mechanistic component
of acid reflux in chronic cough is when it rises to the level of the airway where acid can potentially
be aspirated. We further wished to determine if multi-sample exhaled breath condensate (EBC) pH
profiles can identify chronic cough patients likely to respond to proton pump inhibitor therapy.
Methods: 59 subjects were recruited for this study. Initially we examined EBC pH (gas-
standardized with Argon) in the setting of 15 experimental pharyngeal acid challenges to determine
duration of EBC acidification. Subsequently, we enrolled 22 healthy subjects to determine a normal
multi-sample exhaled breath condensate pH profile over 1–3 days. We additionally obtained multi-
sample EBC pH profiles in 22 patients with chronic cough. These samples were timed to occur after
coughing episodes. Exhaled breath condensate pH was measured after gas standardization.
Results: We found that exhaled breath condensate pH is substantially reduced for approximately
15 minutes after pharyngeal acid load. Healthy subjects rarely have any low EBC pH values (defined
as < 7.4 based on a normative reference range from 404 healthy subjects). Patients with chronic
cough who subsequently responded well to proton pump inhibition (n = 8) invariably had one or
more cough episodes associated with EBC acidification. No patient who had normal EBC pH with
each of their cough episodes reported a clinically relevant response to proton-pump inhibition.
Conclusion: Patients whose cough responds to proton pump inhibition have transient exhaled
breath condensate acidification with coughing episodes, supporting the role of airway acidification
in reflux-triggered cough. Multi-sample EBC pH profiles, involving samples collected immediately
subsequent to a coughing episode, may be useful appropriately to direct therapy to those patients
with cough who have relevant acid reflux.
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Cough is a leading reason patients consult respiratory
physicians. Gastric acid reflux up the esophagus is a well-
recognized cause of chronic cough both in the presence
and absence of underlying lung or airway diseases. Two
mechanisms of this cough have been demonstrated: 1)
reflux high into the laryngeal/hypopharyngeal region
with laryngeal acid contact with or without aspiration into
the airway; 2) esophageal acid contact. Both of these sites
of acid exposure lead to cough through vagal-mediated
reflex pathways and neurogenic inflammation, but
importantly the first also leads to the diverse pathologies
resulting from the direct acid injury to the airway[1]. In
this project we tested the hypothesis that acid reflux to the
level of the airway is a critical component for the trigger-
ing of cough in acid reflux cough.
Data are mixed about the utility of proton pump inhibi-
tion (PPI) for the treatment of suspected acid reflux
cough[2,3], and in the United States no PPI is approved
by the government for marketing and sale for this pur-
pose. Yet, respiratory medicine physicians and otolaryn-
gologists prescribe PPI's frequently, and with some
confidence that they are effective for respiratory manifes-
tations of acid reflux. We have been curious as to why
there is a discrepancy between the equivocal efficacy of
these medications in certain published studies and the
evident utility of these medications in actual practice.
One explanation is that studies have enrolled the wrong
patients. Most studies of acid reflux cough were designed
to recruit subjects with respiratory symptoms who also
had symptomatic or esophageal pH probe evidence of
gastro-esophageal reflux disease (GERD). However, the
amount of acid in the airway necessary to trigger airway
symptoms such as cough is substantially lower than the
amount of acid reflux necessary to trigger esophageal
symptoms. Whereas 4% of more esophageal acid contact
time may be abnormal from an esophageal standpoint,
any acid contact time in the airway, even for moments, is
likely capable of causing pronounced symptoms. Esopha-
geal symptoms are commonly not present in patients with
acid reflux cough[4]. And GERD symptoms are common
in patients with asthma and COPD, but may not be rele-
vant in a given patient[3]. For these reasons, enrolling
subjects with GERD when studying the therapeutic effi-
cacy of acid blockade may not be the optimal strategy, and
this design flaw may explain why such studies commonly
report marginal or conflicting results.
We hypothesized that acidification of the hypopharynx,
such as occurs when gastric acid refluxes above the upper
esophageal sphincter into the hypopharynx, should cause
exhaled breath condensate(EBC) to be acidic(after gas-
standardization). We examined this hypothesis by means
of pharyngeal acid challenges. We then tested for sponta-
neous hypopharyngeal gastric acid reflux by performing
EBC pH testing in patients suspected of having acid reflux
cough based on history and physical examination. Over a
period of one or more days, we tested for acidic breath
multiple times per subject, within several minutes of
coughing episodes. We compared the EBC pH profiles
thus obtained with responsiveness of the chronic cough to
a 1 month treatment course with twice daily PPI therapy.
This comparison allowed an examination of the ability of
the EBC pH profile to predict responsiveness to PPI ther-
apy, which functions as a diagnostic gold standard of
sorts. This study design also provided evidence of effec-
tiveness of PPI therapy in the selected population.
Methods
Subjects
56 subjects were recruited from the region of the Univer-
sity of Virginia during 2005. Subjects consisted of patients
with chronic cough derived primarily from the adult and
pediatric pulmonology, allergy and otolaryngology clin-
ics, as well as controls obtained by convenience within the
University. The principal enrollment criterion for chronic
cough patients was the intention of their doctor to initiate
a therapeutic trial of proton pump inhibition as an effort
to make a diagnosis of possible acid reflux cough. Chronic
cough needed to have been present daily for at least 6
weeks. Minimum age was set as 5 years. To assure real-
world utility of the study, subjects with chronic cough
were included without regard to the presence or suspicion
of other diagnoses, but solely on the basis of the physi-
cian's planned therapeutic trial. Exclusion criteria
included use of PPI or H2 antagonists within the past 7
days, or a previous attempt to treat the cough with acid
blockade. Additionally, if other medication regimen
changes were made concurrently, the patients were
excluded. No patients had undergone esophageal pH
probe testing. The studies were approved by the Human
Investigation Committee at the University of Virginia and
all subjects provided informed consent.
Collection of exhaled breath condensate
Individual EBC samples were collected without nose clips
during 5 minutes of relaxed breathing through a single-
use disposable RTube EBC collector (Respiratory
Research, Inc. USA), with initial temperature of between -
4 and -17°C. The RTube device consists of a polypropyl-
ene condensing surface kept chilled with a reusable alumi-
num cover. Two one-way valves serve to direct exhaled air
appropriately through the condenser.
Pharyngeal acid challenge
To determine how long EBC pH might stay abnormal after
a pharyngeal acid challenge, 15 subjects performed EBC
collection in the laboratory followed by rapid ingestion ofPage 2 of 8
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a reverse model of acid reflux. They then collected 6 con-
secutive EBC samples (5 minutes each) for 30 minutes.
For comparison, 5 subjects performed the same set of EBC
collections, but after ingesting 50 milliliters of tap water
(pH 7.8).
Exhaled breath condensate collection for multisample 
testing of EBC pH
Subjects were provided a collection kit consisting of 8 dis-
posable RTube EBC collectors and a pre-addressed express
mailing box (Single Subject Longitudinal airway pH Mon-
itoring Kit, Respiratory Research, Inc, USA). This sampling
procedure was developed specifically to create a multi-
sample EBC pH profile for the subjects, which is a clear
distinction from all previous published EBC studies. The
subjects were asked to collect the 8 EBC samples in their
home or work over a period of 1 to 4 days, to include at
least 2 samples when they had not been coughing for the
previous 1 hour. The remaining samples were requested
to be collected specifically when the subject had experi-
enced a coughing episode within the previous 10 minutes.
Sample collection duration for each collection was
requested to be 5 minutes, and no nose clips were worn.
Temperature of collection was determined by the home
freezer temperature (generally between -4 and -17°C),
which was used to chill the aluminum that provides the
cool temperature for condensation in the RTube collec-
tion system. Subjects were asked to not collect any sam-
ples within one hour of any liquid or food ingestion. After
collection of each sample, the subject wrote the date and
time of collection on the RTube label along with checking
a box to discriminate whether this was a "cough" or "no
cough/well" sample. Each sample was stored in their
home freezer until 4 days had passed or all 8 collections
were completed, whichever came first. At that point, the
subjects placed the RTube EBC samples into the return
mailing container for shipment (2-day) to the investiga-
tors' laboratory. During this shipping, samples thawed
and were not temperature controlled (which had been
shown in preliminary studies to not adversely affect EBC
pH values). Healthy subjects provided 8 EBC samples in
similar fashion as delineated above, but because they had
no cough, the samples were collected at conveniently
spaced times during the course of 1–4 days.
Study protocol
After providing the multiple EBC samples as described
above, chronic cough patients began taking a proton
pump inhibitor as prescribed by their physician. The ther-
apeutic regimen was determined by their doctor, and no
specific medication or dosing was mandated by the study
although all patients were prescribed the medication as a
twice daily regimen. Assessment of response to PPI was
based on a subjective scoring scale performed 1 month
after starting the PPI. Subjects were asked if their cough
was 0, 25, 50, 75 or 100 percent improved. 75 % or better
was determined in advance of the study to be considered
a "PPI responder." An improvement of 0 or 25% was con-
sidered a "non-responder." 50% improvement was con-
sidered an equivocal response.
EBC pH assay
Upon receipt into the laboratory, data were recorded from
the labels of the RTube EBC collectors and the samples
removed by plunging the condensers with the internal
Repeated exhaled breath condensate pH (after gas standardi-zation) before and after pharyngeal challenge by means of an acidic drink (Figure 1A) and aft r water control (Figure 1B)Figure 1
Repeated exhaled breath condensate pH (after gas standardi-
zation) before and after pharyngeal challenge by means of an 
acidic drink (Figure 1A) and after a water control (Figure 1B). 
EBC pH is transiently low after acid challenge, lasting approx-
imately 10 to 15 minutes. * indicates significant differences 
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standardized by bubbling with Argon for 8 minutes at 350
ml/min prior to pH measurement, which was performed
with an Orion pH glass combo microelectrode attached to
an Orion 520 A meter as previously reported[5]. The
probe and meter had been calibrated at pH 4, 7, and 10
with standard as well as low ionic strength calibration
buffers prior to each set of assays.
Definitions of positive and negative EBC pH profiles
A positive EBC pH profile prospectively was defined as
one in which one or more or the patient's coughs occurred
with a concurrent low EBC pH value (equal to pH <7.4,
based on the normative database previously published by
Paget-Brown[6]), while at least one EBC sample collected
by the patient had a normal EBC pH value. A negative EBC
pH profile was defined as one in which none of the sam-
ples performed after cough had a low EBC pH value.
Healthy subjects without cough were considered EBC pH
profile negative by definition (because they had no cough
with which a low EBC pH could occur).
Statistical considerations
The effect on EBC pH of pharyngeal acid challenge was
examined graphically and EBC pH at each time period
compared by ANOVA on Ranks followed by Dunn's test.
Comparison of individual EBC pH values was accom-
plished by Mann-Whitney Rank Sum, and the number of
low EBC pH values for each group compared by Chi-
squared analysis. The ability of the system of EBC collec-
tions and resulting EBC pH profile in each patient to pre-
dict cough responsiveness to PPI therapy was analyzed by
Fisher exact test.
Results
Ingestion of acidic beverage (as an effort to temporarily
acidify the hypopharynx) caused a rapid and pronounced
and significant EBC pH decline that persisted for 10–20
minutes (p < 0.05, Figure 1A). This provided the evidence
to suggest that EBC sample collection initiated by the
patient within 10 minutes of coughing would generally
identify if the pharynx (and possibly lower airway) was
acidic at the time. Ingestion of water did not affect EBC pH
(Figure 1B).
44 subjects were enrolled to provide a full EBC pH profile
by collecting all samples over a 1–4 day period in their
homes. In healthy subjects (n = 22, age 35 ± 17 years), the
median (25–75% range) pH of all EBC samples was 8.1
(8.0–8.2) (n = 174 individual samples) which was essen-
tially identical to the Paget-Brown normative database of
404 individual collections from healthy subjects[6]. In
regards to the EBC pH profile, 18/22 subjects revealed an
EBC pH profile consisting of entirely normal EBC pH val-
ues (defined based on Paget-Brown[6] to be greater than
or equal to 7.4). Of the 174 samples collected from con-
trols, 6 samples had a low EBC pH. Two subjects each had
1 low pH value out of their 8 samples, and two subjects
had 2 low pH values.
22 chronic cough subjects performed the EBC pH profile
(age 28 ± 23 years). These patients were likely to have var-
ious causes of their cough. In these subjects, the median
EBC pH of all the individual samples collected was 7.9
(7.6–8.0, n = 166), which was only minimally, but statis-
tically significantly, lower than controls (p < 0.001). 29/
166 samples revealed a low EBC pH value (p < 0.001 com-
pared to this proportion in controls).
Of the 22 patients prescribed PPI therapy, 17 patients
filled the PPI prescription and initiated therapy as directed
A. Individual isolated exhaled breath condensate pH values immediately after coughing episodes in patients grouped by the response of th ir cough to a subsequent 1 month trial of proton pump inhibitionFigure 2
A. Individual isolated exhaled breath condensate pH values 
immediately after coughing episodes in patients grouped by 
the response of their cough to a subsequent 1 month trial of 
proton pump inhibition. There are multiple samples collected 
from each subject. EBC acidification is significantly more 
common during cough in patients who subsequently respond 
to proton pump inhibition. B. Individual EBC pH data points 
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scription, however follow-up information was available
from all subjects. EBC pH profiles were compared to
responsiveness to PPI therapeutic challenge or to
untreated outcome. After 1 month of therapy with PPI, 8
subjects reported a positive response (75% or more
improvement in cough symptoms) and 9 subjects were
classified as non-responders (0 or 25% improvement). No
subject reported a 50% (equivocal) improvement. Of the
5 patients who did not start the PPI, all reported substan-
tial resolution (75–100%) of symptoms spontaneously.
Subjects whose cough responded to PPI therapy were sig-
nificantly more likely to have one or more of their cough-
ing episodes occurring in the setting of a low EBC pH than
those who did not respond to acid blockade (p = 0.001).
14 out of 32 coughing episodes in these 8 PPI responders
occurred in association with a low EBC pH value, and an
additional 4 had equivocally low pH value (pH = 7.4). Of
the coughing episodes in the 9 PPI non-responders, only
1 out of 47 occurred in association with a low EBC pH,
and none had equivocal values (equivocal = pH 7.4).
These individual assay data points are graphically pre-
sented in Figure 2.
One key purpose of this study was to move away from reli-
ance on analysis of single EBC values, and instead to
investigate EBC pH profiles derived from all samples col-
lected from each individual subject along with the
recorded concurrent symptoms. This was possible because
of the availability of a kit designed for multiple collections
of EBC samples in patients' homes. To demonstrate this
multi-sample EBC pH assay system more clearly, a typical
positive EBC pH profile from this study is shown in Table
2.
Interpreting the data in this context of a multi-sample pro-
file drew a much sharper contrast between PPI responders
and non-responders than did the use of individual collec-
tions. In this study, the predictive value of a positive EBC
pH profile (again, defined as one or more coughs associ-
ated with a low EBC pH value with at least one normal
EBC pH value at another time), in terms of responsiveness
to PPI, was 89%. The predictive value of a negative EBC
pH profile was 100% (Figure 3).
Of the 5 subjects who did not begin taking their PPI med-
ication as prescribed, all showed spontaneous resolution
of the cough when contacted at one month. 4 of these 5
subjects had a negative EBC pH profile.
Three subjects provided a repeated series of EBC collec-
tions in their homes after treatment with PPI and cough
resolution. Although few in number, these EBC pH pro-
files all normalized, with only 1 low EBC pH being found
in 24 samples (8 samples each) with that sample having
been obtained in the absence of preceding cough).
Discussion
The EBC pH profile developed for this project is novel
methodology that distinguishes this approach from previ-
ous investigative efforts in which only individual data
points were evaluated.
In this study, the presence of one or more episodes of
cough with a concurrent low EBC pH value in any sub-
ject's EBC pH profile strongly predicted responsiveness of
the cough to proton-pump inhibition. In the absence of
any coughing episodes occurring in association with a low
EBC pH value, the patient's responsiveness to proton
pump inhibition was minimal or non-existent. The
patients were recruited into this study based on the inten-
tion of their respiratory medicine physician to initiate a
trial of proton pump inhibition for suspected acid-reflux
cough. Despite being enrolled from a subspecialty clinic,
half of such patients did not respond to a one-month trial
Multi-sample EBC pH profiles of controls and patientsFigure 3
Multi-sample EBC pH profiles of controls and patients. 
Chronic cough patients are separated into three groups: 
those who subsequently showed minimal or no response to 
proton pump inhibition (PPI Non-responders); those who 
had substantial clinical response to proton pump inhibition 
(PPI responders), and those who elected to not take the pre-
scribed proton pump inhibitor but who nonetheless had sub-
stantial improvement in cough (Spontaneous Resolver). EBC 
pH profiles are noted as positive if a cough was associated 
with a low EBC pH value on 1 or more occasions and one or 
more other EBC pH values was normal. Note the high pre-
dictive values of positive and negative EBC pH profiles for 
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ures could be well identified by a multi-sample EBC pH
profile revealing a series of coughs associated with normal
EBC pH values.
Trials of proton pump inhibition have become common
for diagnosis of respiratory symptoms associated with
acid reflux[7]. This standard is tarnished by the expense
and the long period sometimes necessary for efficacy to be
evident (1–3 months in most studies). Spontaneous reso-
lution of various causes of chronic cough certainly occurs,
and indeed is revealed in the 5 patients in our study who
did not start their prescribed PPI therapy. Spontaneous
resolution occurring during a PPI therapeutic trial leads to
misdiagnoses, and prolonged courses of unnecessary and
expensive medication. PPI therapeutic trials also suffer
from confusion in the setting of asthma, chronic obstruc-
tive pulmonary disease or other respiratory conditions,
which may undergo exacerbation coincidently during a
PPI trial, making the PPI trial seem ineffective.
Esophageal pH probes are not sufficiently helpful for
diagnosis of acid reflux cough. They are expensive,
uncomfortable, and neither particularly sensitive nor spe-
cific[8]. In clinical practice, esophageal pH probes are
most commonly interpreted by gastroenterologists, using
criteria developed for GERD diagnosis, which when con-
sidered carefully are fairly irrelevant to acid-reflux induced
respiratory disease. What is considered a normal amount
of acid reflux by these criteria may be profoundly abnor-
mal if each acid event reaches the larynx and triggers
cough. The presence of abnormal GER is very common in
obstructive lung disease and it is unwise to be confident
that it is causing cough just because it is present. Nasopha-
ryngeal or hypopharyngeal placement of a pH probe sen-
sor is particularly uncomfortable for the patient, and is
generally reserved for research use. No effort was made to
compare EBC pH with invasively measured pharyngeal
pH in this study, although that is being undertaken.
Our findings regarding EBC pH and responsiveness to
proton pump inhibition differ from those published
recently[9], but then the methodology is also different.
The previous study of EBC pH in chronic cough used a
large non-portable EBC collection device, and therefore
the timing of the sample collection was one of conven-
ience in association with a study clinic visit, and not
related to an active cough. We provided disposable, port-
able EBC collectors for the patients to use in their homes,
which allowed for targeting of sample collection to within
minutes of a coughing episode. If acid reflux was contrib-
uting to their cough through hypopharyngeal/laryngeal/
tracheal acidification, the EBC pH effect should be brief. If
there is only a 0.1 % hypopharyngeal acid contact time,
consisting of multiple brief acid reflux events, there will
only be 0.1% of the day when the pH will be low.
Although this brief acid exposure may be sufficient to
cause frequent cough, it will only be identified if the
breath sample is collected when the coughing occurs.
Therefore timing is critical. This key element of our meth-
odology, using the symptoms of cough to prompt the
patient to perform the EBC collections, allows for relevant
acid reflux event to be identified, no matter how infre-
quent and brief.
A final, and critical, difference is that we collected multi-
ple samples from each subject to develop an EBC pH pro-
file, and this profile allows for much greater sensitivity of
the procedure by enhancing the likelihood of finding a
correlation of cough with acidity if it is indeed present in
a given patient.
Coughing may trigger a pharyngeal reflux event, although
studies specifically examining concurrent acid reflux and
cough find that it is far more common for the reflux to
precede the cough[10]. Although we cannot exclude the
possibility that in some patients a low EBC pH may result
from reflux secondary to cough, this seems unlikely given
our data. In this regard, those patients who subsequently
did not respond to proton pump inhibition nonetheless
had substantial cough symptoms, but without low EBC
pH values.
EBC pH has been reported to be low in acute asthma, sta-
ble moderate-to-severe asthma, COPD, and the common
cold[1]. We believe it is a mistake to attribute each of these
to acid reflux and aspiration. Acid reflux can certainly
acidify the airway, but it is just one of several pathways
leading to airway acidification. Acids emanating from any
level of the airway can contribute to the exhaled acids that
Table 1: Subject characteristics
Subgroup Age (years) Sex EBC pH Median (25–75% range)
Pharyngeal Acid Challenge (n = 15) 28.8 ± 10 10 F
5 M
8.0 (7.9–8.0) (n = 15 samples from before challenge)
Normal Subjects (n = 22) 35.17 13 F
9 M
8.1 (8.0–8.2) (n = 174 samples)
Chronic Cough Subjects (n = 22) 28 ± 23 7 F
15 M
7.9 (7.6–8.0) (n = 166 samples)Page 6 of 8
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patients reveals values essentially identical to normal
orally-breathing controls[5], but patients intubated for
respiratory illness have been found to have low EBC pH
even when there is a cuffed endotracheal tube in place[13]
(which will decrease, although not totally eliminate, aspi-
ration). Acidification occurs with inflammation in most
every other fluid in the body; there is no reason to think it
should be any different for the airway lining fluid.
Distinguishing acid reflux-induced airway acidification
from primary lower airway acidification possibly may be
accomplished by seeing normal EBC pH values close in
time to low EBC pH values. Reflux leads to rapid airway
acidification (at least of the hypopharynx, and in many
cases the tracheobronchial tree as well). Rate of neutrali-
zation of this acid insult likely varies, but seems to be
rapid in general. A persistently low EBC pH value over the
course of hours may be more suggestive of an acidification
process other than reflux.
Our study would have benefited from a more objective
cough score as opposed to a subjective scoring system that
has not undergone extensive validation. However, we
believe this is overcome in this study because the determi-
nation as a PPI responder or a non-responder (in terms of
subjective cough score) was in no case equivocal. The
number of subjects enrolled was sufficient to identify a
highly statistically significant association between a low
EBC pH (with cough) and responsiveness of cough to pro-
ton pump inhibition.
Although there was a trend for different sex distributions
between the control groups and the coughing subjects,
there were no statistically significant differences in the
sexes (by Fisher Exact Test). Additionally, there were no
statistically significant differences in the ages of the groups
(by ANOVA). However, as a general comment on the like-
lihood that a patient will respond to PPI therapy, there
was a trend for the PPI responsive group to be younger
than the PPI non-responders.
Conclusion
In conclusion, we have tested the ability of serial (multi-
sample) collections of exhaled breath condensate with
gas-standardized pH measurement to identify – with high
positive and negative predictive values – the likelihood of
a patient having a positive response to proton pump inhi-
bition prescribed for their chronic cough. Our data sug-
gest that airway acidification occurs in PPI responders,
supporting that hypopharyngeal acidification and proba-
bly microaspiration are important contributors to PPI
responsive acid reflux cough.
Multi-sample measurements of EBC pH in potential study
volunteers may be able to decrease the confounding influ-
ence of acid reflux cough in future studies designed to test
the efficacy of new therapies aimed at the non-acid com-
ponents of COPD, asthma, and other respiratory diseases.
This method of serial EBC pH testing allows for earlier
non-invasive diagnosis of acid reflux as a cause of a
patient's cough. It should also help more rapidly and effi-
ciently direct the use of PPI medications to the patients
likely to respond. Although not yet studied, it is reasona-
ble to expect that this non-invasive tool will lead to more
efficient use of medical resources, for example limiting the
need for pH probes. This testing has recently started to be
used in clinical practice and represents the maturation of
the EBC research technique into a rational clinical diag-
nostic.
Abbreviations
EBC Exhaled Breath Condensate
PPI Proton Pump Inhibitor
GER Gastroesophageal Reflux
GERD Gastroesophageal Reflux Disease
Table 2: Positive EBC pH profile in a chronic cough patient who subsequently responded well to proton pump inhibition. Note that the 
patient provides multiple EBC samples over the course of 1 – 2 days, both immediately after coughing, and in the absence of a recent 
cough (none in previous 1 hour). There are several cough episodes for which there is a low EBC pH value, while other values are 
normal (revealing transience of the low EBC pH value in this chronic cough patient)
Date Time Symptom EBC pH
12/26/04 1545 Cough 8.3
12/26/04 1745 Cough 5.0
12/26/04 1945 Cough 7.9
12/27/04 1015 Cough 6.0
12/27/04 1215 Cough 7.7
12/27/04 1730 Well 8.1
12/27/04 1930 Well 7.7
12/27/04 2130 Cough 5.8Page 7 of 8
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